248 related articles for article (PubMed ID: 21220322)
1. Cellular and molecular events in the localization of diabetogenic T cells to islets of Langerhans.
Calderon B; Carrero JA; Miller MJ; Unanue ER
Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1561-6. PubMed ID: 21220322
[TBL] [Abstract][Full Text] [Related]
2. Entry of diabetogenic T cells into islets induces changes that lead to amplification of the cellular response.
Calderon B; Carrero JA; Miller MJ; Unanue ER
Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1567-72. PubMed ID: 21220309
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies and CD4 T cells target a beta cell retroviral envelope protein in non-obese diabetic mice.
Levisetti MG; Suri A; Vidavsky I; Gross ML; Kanagawa O; Unanue ER
Int Immunol; 2003 Dec; 15(12):1473-83. PubMed ID: 14645156
[TBL] [Abstract][Full Text] [Related]
4. Thymic positive selection and peripheral activation of islet antigen-specific T cells: separation of two diabetogenic steps by an I-A(g7) class II MHC beta-chain mutant.
Kanagawa O; Vaupel BA; Xu G; Unanue ER; Katz JD
J Immunol; 1998 Nov; 161(9):4489-92. PubMed ID: 9794372
[TBL] [Abstract][Full Text] [Related]
5. Detection and characterization of T cells specific for BDC2.5 T cell-stimulating peptides.
You S; Chen C; Lee WH; Wu CH; Judkowski V; Pinilla C; Wilson DB; Liu CP
J Immunol; 2003 Apr; 170(8):4011-20. PubMed ID: 12682229
[TBL] [Abstract][Full Text] [Related]
6. Suppression of diabetes mellitus in the non-obese diabetic (NOD) mouse by an autoreactive (anti-I-Ag7) islet-derived CD4+ T-cell line.
Chosich N; Harrison LC
Diabetologia; 1993 Aug; 36(8):716-21. PubMed ID: 8405738
[TBL] [Abstract][Full Text] [Related]
7. Regulation of diabetes development by regulatory T cells in pancreatic islet antigen-specific TCR transgenic nonobese diabetic mice.
Kanagawa O; Militech A; Vaupel BA
J Immunol; 2002 Jun; 168(12):6159-64. PubMed ID: 12055228
[TBL] [Abstract][Full Text] [Related]
8. T cell islet accumulation in type 1 diabetes is a tightly regulated, cell-autonomous event.
Lennon GP; Bettini M; Burton AR; Vincent E; Arnold PY; Santamaria P; Vignali DA
Immunity; 2009 Oct; 31(4):643-53. PubMed ID: 19818656
[TBL] [Abstract][Full Text] [Related]
9. CD4+ CD25+ regulatory T cells prevent type 1 diabetes preceded by dendritic cell-dominant invasive insulitis by affecting chemotaxis and local invasiveness of dendritic cells.
Lee MH; Lee WH; Todorov I; Liu CP
J Immunol; 2010 Aug; 185(4):2493-501. PubMed ID: 20639483
[TBL] [Abstract][Full Text] [Related]
10. Cross-priming of diabetogenic T cells dissociated from CTL-induced shedding of beta cell autoantigens.
Yamanouchi J; Verdaguer J; Han B; Amrani A; Serra P; Santamaria P
J Immunol; 2003 Dec; 171(12):6900-9. PubMed ID: 14662897
[TBL] [Abstract][Full Text] [Related]
11. IFNγ-Induced MHC Class II Expression on Islet Endothelial Cells Is an Early Marker of Insulitis but Is Not Required for Diabetogenic CD4
Scott NA; Zhao Y; Krishnamurthy B; Mannering SI; Kay TWH; Thomas HE
Front Immunol; 2018; 9():2800. PubMed ID: 30555479
[TBL] [Abstract][Full Text] [Related]
12. B7-2 (CD86) controls the priming of autoreactive CD4 T cell response against pancreatic islets.
Yadav D; Judkowski V; Flodstrom-Tullberg M; Sterling L; Redmond WL; Sherman L; Sarvetnick N
J Immunol; 2004 Sep; 173(6):3631-9. PubMed ID: 15356107
[TBL] [Abstract][Full Text] [Related]
13. Adoptive transfer of islet antigen-autoreactive T cell clones to transgenic NOD.Ea(d)mice induces diabetes indicating a lack of I-E mediated protection against activated effector T cells.
Roberts SA; Barbour G; Matarrese MR; Mason DL; Leiter EH; Haskins K; Hanson MS
J Autoimmun; 2003 Sep; 21(2):139-47. PubMed ID: 12935783
[TBL] [Abstract][Full Text] [Related]
14. Breakpoints in immunoregulation required for Th1 cells to induce diabetes.
Neighbors M; Hartley SB; Xu X; Castro AG; Bouley DM; O'Garra A
Eur J Immunol; 2006 Sep; 36(9):2315-23. PubMed ID: 16933361
[TBL] [Abstract][Full Text] [Related]
15. Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis.
Hussain S; Delovitch TL
J Immunol; 2005 Jan; 174(2):680-7. PubMed ID: 15634886
[TBL] [Abstract][Full Text] [Related]
16. Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta-cell cytotoxic CD8+ T-cell clones in vivo.
Utsugi T; Yoon JW; Park BJ; Imamura M; Averill N; Kawazu S; Santamaria P
Diabetes; 1996 Aug; 45(8):1121-31. PubMed ID: 8690161
[TBL] [Abstract][Full Text] [Related]
17. The influence of the major histocompatibility complex on development of autoimmune diabetes in RIP-B7.1 mice.
Wong FS; Du W; Thomas IJ; Wen L
Diabetes; 2005 Jul; 54(7):2032-40. PubMed ID: 15983204
[TBL] [Abstract][Full Text] [Related]
18. TCR affinity and tolerance mechanisms converge to shape T cell diabetogenic potential.
Bettini M; Blanchfield L; Castellaw A; Zhang Q; Nakayama M; Smeltzer MP; Zhang H; Hogquist KA; Evavold BD; Vignali DA
J Immunol; 2014 Jul; 193(2):571-9. PubMed ID: 24943217
[TBL] [Abstract][Full Text] [Related]
19. Low TCR signal strength induces combined expansion of Th2 and regulatory T cell populations that protect mice from the development of type 1 diabetes.
Turner MS; Isse K; Fischer DK; Turnquist HR; Morel PA
Diabetologia; 2014 Jul; 57(7):1428-36. PubMed ID: 24737163
[TBL] [Abstract][Full Text] [Related]
20. T-bet-deficient NOD mice are protected from diabetes due to defects in both T cell and innate immune system function.
Esensten JH; Lee MR; Glimcher LH; Bluestone JA
J Immunol; 2009 Jul; 183(1):75-82. PubMed ID: 19535634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
